
Loading, please wait...

Loading, please wait...

Q1: Who does the UK lifetime smoking ban affect?
The law applies to anyone born on or after January 1, 2009. In practice, this means these individuals will never be able to legally purchase tobacco products in their lifetime.
Q2: Does the new bill include restrictions on electronic cigarettes?
Yes, the legislation tightens rules on vaping. It specifically bans sales to minors and grants powers to regulate flavors, packaging, and advertising to prevent youth addiction.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


UK lawmakers pass the Tobacco and Vapes Bill, creating a lifetime smoking ban for those born after 2009 to reduce nicotine addiction and health costs....
6 months ago

Novel glucose-responsive mPEG-PSA nanocarriers deliver insulin aspart on demand, achieving dual postprandial and basal glycemic control without hypoglycemia in diabetic models. This biomaterial breakthrough offers promising clinical implications for physiologic diabetes management.
Today

A novel folate-conjugated tecto-dendrimer nanoplatform successfully delivers siRNA to achieve targeted HK2 silencing, disrupting ovarian cancer glycolysis and suppressing lactate output.
Today

A comparative non-contact study reveals that high-power radiofrequency delivery with the QDOT MICRO catheter induces an artifactual contact force rise. Electrophysiologists must understand this power-dependent thermal and electrical phenomenon to avoid inadvertent catheter withdrawal and ineffective ablation.
Today

A novel proof-of-concept study presents a six-degree-of-freedom articulated manikin neck equipped with linear potentiometers. The system provides real-time kinematic motion feedback during cervical immobilisation, delivering sub-degree tracking accuracy to improve pre-hospital trauma training and patient safety.
Today

A retrospective comparative cohort study evaluated genitourinary safety in HFpEF between dapagliflozin and empagliflozin over six months. Rates of symptomatic UTI and asymptomatic bacteriuria showed no statistically significant differences, supporting comparable safety profiles across both SGLT2 inhibitors.
Today